Stockscreener 앱 받기
19.96
4.95%
-1.04
시간 외 거래:
20.06
0.10
+0.50%
전일 마감가:
$21.00
열려 있는:
$20.73
하루 거래량:
64,561
Relative Volume:
0.87
시가총액:
$206.70M
수익:
$88.50M
순이익/손실:
$-35.27M
주가수익비율:
-6.0569
EPS:
-3.2954
순현금흐름:
$-23.70M
1주 성능:
-9.89%
1개월 성능:
+30.20%
6개월 성능:
+153.30%
1년 성능:
+225.61%
1일 변동 폭
$19.56
$21.20
1주일 범위
$19.56
$23.32
52주 변동 폭
$5.26
$24.92
바이오데식스 Stock (BDSX) Company Profile
명칭
Biodesix Inc
전화
303-417-0500
주소
919 WEST DILLON ROAD, LOUISVILLE
Compare BDSX vs TMO, DHR, IDXX, NTRA, A
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
19.96 | 217.47M | 88.50M | -35.27M | -23.70M | -3.2954 |
TMO
Thermo Fisher Scientific Inc
|
543.19 | 198.93B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
205.01 | 142.11B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
576.07 | 43.94B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
269.83 | 39.72B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
136.10 | 38.05B | 7.23B | 1.41B | 1.09B | 4.979 |
바이오데식스 Stock (BDSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-27 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2025-05-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-09-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-07-26 | 개시 | Craig Hallum | Buy |
| 2024-05-13 | 개시 | TD Cowen | Buy |
| 2024-05-03 | 개시 | Lake Street | Buy |
| 2021-11-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | 개시 | BTIG Research | Buy |
| 2020-11-23 | 개시 | Canaccord Genuity | Buy |
| 2020-11-23 | 개시 | Morgan Stanley | Overweight |
| 2020-11-23 | 개시 | William Blair | Outperform |
모두보기
바이오데식스 주식(BDSX)의 최신 뉴스
Biodesix Inc. (BDSX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to Trade - MSN
AIGH Capital Management LLC Buys Shares of 758,328 Biodesix, Inc. $BDSX - MarketBeat
Biodesix Inc. (BDSX) Edges Lower Amid Consolidation Near ResistanceMFI Overbought - dars.gov.et
Biodesix (BDSX) chair converts 1,361 RSUs and updates holdings - Stock Titan
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell Microcap Value Benchmark Index - marketscreener.com
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell 3000E Growth Benchmark - marketscreener.com
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell Microcap Index - marketscreener.com
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell 3000E Value Benchmark - marketscreener.com
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell 3000E Index - marketscreener.com
Enterprise value to revenue forward of Biodesix, Inc. – NASDAQ:BDSX - TradingView
Price to earnings forward of Biodesix, Inc. – NASDAQ:BDSX - TradingView
Price to book forward of Biodesix, Inc. – NASDAQ:BDSX - TradingView
Biodesix, Inc. Actuals & Estimates (NASDAQ:BDSX) - TradingView
Biodesix (BDSX) Stock Gets Fair Value Bump As Analysts Back Growth Path - Yahoo Finance
Biodesix, Inc. Actuals & Estimates (BOATS:BDSX) - TradingView
BDSX Forecast — Price Target — Prediction for 2027 - TradingView
BDSX Initiated Coverage by Roth Capital -- Price Target Set at $32 - GuruFocus
Roth Capital Initiates Biodesix at Buy With $32 Price Target - marketscreener.com
Biodesix (BDSX) Coverage Initiated with Positive Outlook - GuruFocus
Biodesix | SCHEDULE 13G/A: Others - Moomoo
Biodesix Inc (BDSX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Biodesix (BDSX) Surges 10.43%: Key Levels and What Lies AheadLow Volume Node - dars.gov.et
Biodesix (BDSX) surges 10.5%: Is this an indication of further gains? - MSN
Biodesix Inc. (BDSX) Surges Over 10%: Key Levels to Watch After the BreakoutETF Inflow Streak - DonanımHaber
Are medical stocks lagging Biodesix (BDSX) this year? - MSN
Biodesix (BDSX) Surges 10.5%: Is This an Indication of Further Gains? - Yahoo Finance
BDSX News | BIODESIX INC (NASDAQ:BDSX) - ChartMill
Soleus discloses 525,241-share (5.1%) stake in Biodesix (BDSX) - Stock Titan
Canaccord raises Biodesix stock price target to $27 on growth outlook By Investing.com - Investing.com Australia
Canaccord raises Biodesix stock price target to $27 on growth outlook - Investing.com UK
Biodesix Inc (BDSX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Biodesix Inc (BDSX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Biodesix Inc (BDSX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Biodesix Inc (BDSX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Biodesix Inc (BDSX) Institutional Confidence - TradingKey
BDSX Technical Analysis & Stock Price Forecast - Intellectia AI
Biodesix Inc (BDSX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Biodesix Inc (BDSX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biodesix Inc (BDSX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BDSX Initiates Coverage On HC Wainwright & Co. -- Rating Set to Buy - GuruFocus
Are Medical Stocks Lagging Biodesix (BDSX) This Year? - Yahoo Finance
HC Wainwright Initiates Biodesix at Buy With $26 Price Target - marketscreener.com
H.C. Wainwright Initiates Biodesix(BDSX.US) With Buy Rating, Announces Target Price $26 - Moomoo
Biodesix, Inc. (BDSX) reports Q1 loss, tops revenue estimates - MSN
BDSX Q1 2026 Earnings: EPS Beat on Lower-Than-Expected Loss; Stock Dips SlightlyLow Growth Earnings - newsline.com
BDSX Q1 2026 Earnings: EPS Surpasses Estimates Despite Net Loss, Stock Ticks DownEarnings Turnaround - newsline.com
Biodesix (BDSX) Tests Resistance After Modest Gain Amid Sector VolatilityVWAP Deviation - newsline.com
Biodesix Inc. (BDSX) Shows Resilience: Shares Gain 2.08% Amid Sector InterestAccumulation Line - newsline.com
Zacks Industry Outlook Highlights BrightSpring Health Services, Biodesix and HealthEquity - sharewise.com
바이오데식스 (BDSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.79%
자본화:
|
볼륨(24시간):